h.bhattacharya
TL2 · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 21 August 2025 · last posted 1d
78 posts, newest first. Showing up to 150.
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #25 · Analytics › Mass spectrometry · 26 Jul 2026 · 19 likes Taking post #24 at face value and following it one step further. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
-
Seven-day rolling means and why weekly readings mislead Replied, post #79 · Outcomes › Progress reports · 21 Jul 2026 · 0 likes Taking post #76 at face value and following it one step further. On seven-day rolling I would separate what is worth knowing from what is worth acting on. The first…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #92 · Evidence › Journal club · 20 Jul 2026 · 0 likes The arithmetic in post #91 is right; the assumption feeding it is the part to check. The most common failure mode is spending fifty minutes on the effect size and ten…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #23 · Clinical › Comorbidities · 15 Jul 2026 · 33 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied. This is the version I would want a…
-
Pages past their review date, listed — does this still hold? Replied, post #51 · Meta › Wiki maintenance · 13 Jul 2026 · 7 likes A methods point on Pages past rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
What is genuinely unknown about long-term amylin agonism Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 21 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #36 · Evidence › Trials · 5 Jul 2026 · 2 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. The documentation on Primary endpoint hierarchies is better than…
-
NHS criteria and how they are applied in practice Replied, post #20 · Regional › UK & Ireland · 5 Jul 2026 · 3 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #15 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 6 likes If someone has run 99.2% and 97.8% properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #105 · Outcomes › Body composition · 30 Jun 2026 · 9 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #82 · Start Here › How to Ask · 29 Jun 2026 · 16 likes Worth separating two things that post #78 runs together. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #4 · marked as the solution · Compounds › Retatrutide · 23 Jun 2026 · 7 likes The opening post is right about the mechanism and I think understates the practical bit. The practical version of TRIUMPH is three sentences long. The rigorous version…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #33 · Compounds › Retatrutide · 14 Jun 2026 · 3 likes The practical version of TRIUMPH is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #100 · Sourcing › Logistics · 13 Jun 2026 · 21 likes The honest answer on Regional warehouse stock versus direct is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how…
-
The headache that turns out to be dehydration — the long version Replied, post #42 · Nutrition & Training › Hydration & electrolytes · 28 May 2026 · 0 likes What I want from this headache thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #27 · Compounds › Repair & healing peptides · 18 May 2026 · 7 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #64 · Clinical › Bloodwork · 11 May 2026 · 21 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Request: show the solution author in the topic list — what changed since Replied, post #86 · Meta › Feature requests · 4 May 2026 · 28 likes Narrowing post #85, because the general version has more than one answer. Request: an export of my own posts. Not for any dramatic reason — I want to search my own…
-
Batch numbers that do not match the vial label — what changed since Replied, post #6 · Sourcing › Red flags · 2 May 2026 · 23 likes Saving this. It is the version I will quote when the question comes round again.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #100 · Practice › Dosing & titration · 28 Apr 2026 · 29 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #119 · Clinical › Special populations · 21 Apr 2026 · 0 likes Adding the measurement that post #116 says would settle it. Extrapolating a point estimate to somebody well outside the enrolled range should be described as an…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #8 · Evidence › Study critique · 21 Apr 2026 · 22 likes The most useful thing anyone has posted about Measurement error in this category was a table of what had been measured and by whom. That is what I would want again.
-
Five questions in one post gets you one answer — how to split them Replied, post #57 · Start Here › How to Ask · 17 Apr 2026 · 9 likes I read post #55 twice before replying, because I had assumed the opposite. Number your questions if there is more than one. It sounds fussy. It means the answer can be…
-
Why the timeline is on the right and not the left — what changed since Replied, post #19 · Meta › Site feedback · 12 Apr 2026 · 0 likes Adding the measurement that post #18 says would settle it. Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #64 · Analytics › Mass spectrometry · 8 Apr 2026 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #62 · Practice › Administration · 6 Apr 2026 · 33 likes Post #61 is right about the mechanism and I think understates the practical bit. Bleeding at the site is common and unremarkable at these needle gauges. Persistent…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Started this topic · Practice › Reconstitution · 3 Apr 2026 · 0 likes Posting this under the heading it deserves: A vial that will not fully dissolve: what to check and in what order Everything below is what sits behind that. Practical…
-
Second pass at: Identical chromatograms across two different lots Replied, post #89 · Sourcing › Red flags · 23 Mar 2026 · 1 like Narrowing post #88, because the general version has more than one answer. Nothing here should be read as an accusation against a named company, and the guidelines exist…
-
Recording a dissent on a document rather than suppressing it Replied, post #8 · Documentation › Doc review · 18 Mar 2026 · 0 likes Post #5 is the version of this I will quote in future. One addition. The most useful review comment names a sentence and says what is wrong with it. General approval…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #6 · Evidence › Trials · 10 Mar 2026 · 22 likes Post #4 describes the usual case. This is about the unusual one. Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #22 · Practice › Administration · 18 Feb 2026 · 10 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I…
-
A plateau that disappeared when I changed how I measured Replied, post #14 · Outcomes › Progress reports · 8 Feb 2026 · 27 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #18 · Pharmacology › Pharmacokinetics · 18 Jan 2026 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Worth separating Washout as a question about the compound from…
-
Research-use-only labelling: what it means and what it does not Replied, post #82 · Sourcing › Regulatory · 3 Jan 2026 · 1 like The bit of research-use-only labelling that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #44 · Access › Pricing · 24 Dec 2025 · 24 likes Narrowing post #43, because the general version has more than one answer. The cost of an independent submission is worth stating in these threads, because it is the…
-
Request: a diff view for wiki revisions — the long version Replied, post #87 · Meta › Feature requests · 21 Dec 2025 · 6 likes Narrowing post #84, because the general version has more than one answer. Since diff view for wiki revisions keeps coming up, it should probably be a maintained page…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #67 · Compounds › Semaglutide · 12 Dec 2025 · 1 like Worth separating two things that post #63 runs together. The mass figure differs between sources because of how the different entities report it. The monoisotopic mass…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #97 · Practice › Reconstitution · 27 Nov 2025 · 5 likes Working out the concentration after the fact from the volume you added is fine. Working it out from the volume you meant to add is where the errors come from — read the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #72 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Post #68 describes the usual case. This is about the unusual one. Working out the concentration after the fact from the volume you added is fine. Working it out from…
-
How this community escalates rather than diagnoses Replied, post #5 · Safety › Adverse events · 25 Nov 2025 · 12 likes Adding the measurement that post #4 says would settle it. Where a member describes something concerning, escalating the thread rather than continuing it is a moderation…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #51 · Compounds › Other compounds · 24 Nov 2025 · 0 likes No notes. Posting so the count is not one.
-
How to ask about something you suspect is a bad idea Replied, post #26 · Start Here › How to Ask · 18 Nov 2025 · 19 likes Post #23 is right about the mechanism and I think understates the practical bit. Units. Everything needs units. This is why we ask every single time. I have seen the…
-
[2026 update] What steady state means for the decision to escalate Replied, post #47 · Practice › Dosing & titration · 10 Nov 2025 · 20 likes Whatever the answer on steady state turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #19 · Sourcing › Regulatory · 7 Nov 2025 · 17 likes Coming back to post #17, because the follow-up matters more than the original answer. Import rules for personal quantities differ from commercial import rules and both…
-
Angle of injection and whether 90 degrees is always right Replied, post #41 · Practice › Administration · 26 Oct 2025 · 6 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #6 · Start Here › Welcome · 26 Oct 2025 · 32 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #8 · Compounds › Tirzepatide · 29 Sep 2025 · 29 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Documenting an adverse event properly Replied, post #7 · Safety › Adverse events · 13 Sep 2025 · 3 likes An update on my earlier documenting an adverse event post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #32 · Evidence › Journal club · 20 Aug 2025 · 8 likes Adding the measurement that post #31 says would settle it. One caution on orforglipron phase 2: everything above assumes the underlying documentation is what it claims…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #3 · Practice › Side effects · 18 Aug 2025 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. A symptom that starts weeks after a dose has been stable is a different observation…
-
What this community means by "a source", in practical terms Replied, post #63 · Start Here › Welcome · 8 Aug 2025 · 4 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Interpreting a composition change that is within the error bars Replied, post #10 · Outcomes › Body composition · 1 Jul 2025 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Interpreting a composition change came up in a thread eighteen months ago and was answered…
-
Sodium, potassium and magnesium when intake drops Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 29 Jun 2025 · 31 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. Summarising the sodium thread so far, since it is long and the…
-
A well-designed study with a badly written abstract Replied, post #122 · Evidence › Study critique · 1 Jun 2025 · 19 likes Marking my uncertainty on well-designed study explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #97 · Clinical › Comorbidities · 28 May 2025 · 26 likes On post #95 — agreed on the reasoning, with one qualification. Thyroid history and the C-cell finding is the clearest documented contraindication in this class and is…
-
Pregnancy as an absolute contraindication Replied, post #6 · Safety › Contraindications · 16 May 2025 · 25 likes Adding the measurement that post #3 says would settle it. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #99 · Access › Pricing · 13 May 2025 · 13 likes Building on post #97 rather than restating it. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial…
-
Counter-ion content and its effect on measured mass Replied, post #35 · Analytics › Mass spectrometry · 9 May 2025 · 10 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.…
-
Scheduled maintenance and what will be unavailable Replied, post #128 · Meta › Announcements · 29 Apr 2025 · 15 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Revisiting: German, French and Dutch differences, compared Replied, post #11 · Regional › European Union · 12 Apr 2025 · 10 likes Post #9 put the caveat in the right place and I want to underline it. The public assessment report published at authorisation is one of the best free technical…
-
Ipamorelin selectivity claims and where they came from Replied, post #23 · Compounds › Secretagogues & GH axis · 25 Mar 2025 · 6 likes Ipamorelin is usually described as selective in that it produces less of an effect on cortisol and prolactin than earlier compounds in the family. Selective is a…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #24 · Compounds › Secretagogues & GH axis · 13 Mar 2025 · 30 likes Marking my uncertainty on Tesamorelin explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #41 · Practice › Reconstitution · 7 Mar 2025 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Consistent declarations and why they matter more than clever ones Replied, post #42 · Sourcing › Logistics · 16 Feb 2025 · 0 likes Post #41 is right about the mechanism and I think understates the practical bit. I read the earlier replies on consistent declarations twice before writing this,…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #44 · Devices › Cold chain · 30 Jan 2025 · 29 likes Whatever the answer on Domestic fridge temperature mapping turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #112 · Compounds › Tirzepatide · 23 Jan 2025 · 2 likes Building on post #111 rather than restating it. Reframing SURPASS-2 slightly, because I think the disagreement is about the question rather than the answer. If the…
-
Follow-up: Individual participant data versus aggregate data Replied, post #94 · Evidence › Meta-analyses · 11 Jan 2025 · 23 likes I had written a reply contradicting post #90 and deleted it. Here is what survived. My understanding of Individual participant data versus aggregate is a few years old…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #53 · Compounds › Semaglutide · 29 Dec 2024 · 24 likes Worth separating two things that post #50 runs together. Practical note on Semaglutide formulation: write down what you expect before you look. The number of times I…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #19 · Compounds › Other compounds · 13 Nov 2024 · 22 likes Building on post #16 rather than restating it. Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #31 · Compounds › Tirzepatide · 11 Nov 2024 · 3 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #83 · Compounds › Other compounds · 30 Oct 2024 · 13 likes I have been on both sides of the Melanocortin agonists argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Promotion criteria, and the one that stops most nominations Replied, post #88 · Documentation › Doc review · 17 Oct 2024 · 10 likes Since promotion criteria keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #67 · Practice › Administration · 30 Sep 2024 · 0 likes Adding a small correction to the site rotation scheme summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #12 · Nutrition & Training › Protein & intake · 14 Sep 2024 · 6 likes Noted, and I have changed what I was going to do on the strength of it.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #70 · Analytics › COA interpretation · 13 Aug 2024 · 0 likes Purity assay versus content assay: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #34 · Compounds › Retatrutide · 18 Jul 2024 · 5 likes The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation in the liver. Mechanistic plausibility in this field has a poor…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #61 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes The claim about Splitting a weekly dose upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
The mass-error checker and its intended scope Replied, post #47 · Data & Tools › Calculators · 13 Jun 2024 · 8 likes Answering the question post #44 raises rather than the one it answers. I changed my mind about mass-error checker after someone here asked me for the source and I could…